The Pathogenic Mechanism of the Mycobacterium ulcerans Virulence Factor, Mycolactone, Depends on Blockade of Protein Translocation into the ER
Open accessThe DOI matches its Crossref record; 61 of the 61 references it cites were found in a registry or an index.
Abstract
Infection with Mycobacterium ulcerans is characterised by tissue necrosis and immunosuppression due to mycolactone, the necessary and sufficient virulence factor for Buruli ulcer disease pathology. Many of its effects are known to involve down-regulation of specific proteins implicated in important cellular processes, such as immune responses and cell adhesion. We have previously shown mycolactone completely blocks the production of LPS-dependent proinflammatory mediators post-transcriptionally. Using polysome profiling we now demonstrate conclusively that mycolactone does not prevent translation of TNF, IL-6 and Cox-2 mRNAs in macrophages. Instead, it inhibits the production of these, along with nearly all other (induced and constitutive) proteins that transit through the ER. This is due to a blockade of protein translocation and subsequent degradation of aberrantly located protein. Several lines of evidence support this transformative explanation of mycolactone function. First, cellular TNF and Cox-2 can be once more detected if the action of the 26S proteasome is inhibited concurrently. Second, restored protein is found in the cytosol, indicating an inability to translocate. Third, in vitro translation assays show mycolactone prevents the translocation of TNF and other proteins into the ER. This is specific as the insertion of tail-anchored proteins into the ER is unaffected showing that the ER remains structurally intact. Fourth, metabolic labelling reveals a near-complete loss of glycosylated and secreted proteins from treated cells, whereas cytosolic proteins are unaffected. Notably, the profound lack of glycosylated and secreted protein production is apparent in a range of different disease-relevant cell types. These studies provide a new mechanism underlying mycolactone's observed pathological activities both in vitro and in vivo. Mycolactone-dependent inhibition of protein translocation into the ER not only explains the deficit of innate cytokines, but also the loss of membrane receptors, adhesion molecules and T-cell cytokines that drive the aetiology of Buruli ulcer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



![Figure 4 Mycolactone inhibits co-translational translocation of proteins into the ER via a mechanism that does not disrupt the structural integrity of the ER. A–E. In vitro translation (IVT) reactions of different capped transcripts were performed as described +/− mycolactone (MYC; 200 ng/ml unless indicated otherwise), Eeyarestatin 1 (ES1; 250 µM) or DMSO (-; 0.02%). Data representative of 3 independent experiments. A. IVT of luciferase and TNF mRNAs detected by 35S incorporation and Western blot (∼26 kDa) respectively. B. IVT of TNF mRNA was performed in the presence of semi-permeabilised RAW264.7 cells then incubated with no addition (-), or Proteinase K (PK) +/−0.1% Triton-x-100 (PKT) for 1 hr at 4°C before stopping the reaction. C. Dose dependence of loss of the PK protected band. Signal intensity was quantified by ImageJ analysis of non-saturated blots and the protected band (PK) was normalised to total pro-TNF (-). D. IVT of prepro-α Factor (PPAF) and β-lactamase (LACTB) mRNAs in the absence or presence of canine pancreatic microsomal membranes (CPMM). Black arrowhead, glycosylated forms of α Factor; *, signal peptide-cleaved LACTB. E. IVT of PPAF, Sec61β and cytochrome B5 (Cyt-B5) mRNAs in the presence CPMM. After labelling with 35S as described, membranes were isolated by centrifugation through a sucrose cushion [31]. Endoglycosidase H (EndoH) is used to confirm glycosylation of proteins (black arrowhead), the thin line represents where an empty lane was removed from the image for ease of interpretation. F. RAW264.7 cells were incubated +/−125 ng/ml mycolactone (MYC), washed and incubated without mycolactone for various periods (recovery time) before stimulating with LPS for 4 hrs. Supernatant TNF levels were measured by ELISA (mean±SEM of triplicate assays).](https://figures.cochat.ai/paper-figures/08c037fe166d42d5b63952ca096a48fd/the-pathogenic-mechanism-of-the-mycobacterium-ulcerans-virulence-factor-figure-4.jpg)


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Interestingly, inhibiting the 29S proteasome showed that non-glycosylated TNF accumulates in the cytoplasm of mycolactone-treated macrophages, indicating that this causes the failure in TNF secretion.”
From Macrophage Cytokines: Involvement in Immunity and Infectious Diseases (2014) · cites this paper as [102]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“These findings were made more general by showing that – in many cell types – mycolactone was inhibiting the translocation of several secreted and membrane proteins into the ER.”
From Macrophage Cytokines: Involvement in Immunity and Infectious Diseases (2014) · cites this paper as [102]
The cited source says what the claim attributes to it.
In the citing paper
“Indeed, Hall et al. found that mycolactone does not cause gross changes in translation, with proinflammatory mRNAs being actively translated (102).”
From Macrophage Cytokines: Involvement in Immunity and Infectious Diseases (2014) · cites this paper as [102]
The cited source says what the claim attributes to it.
In the citing paper
“Importantly, mycolactone blocked the release of several cytokines, chemokines, and other inflammatory mediators from LPS-activated macrophages (102).”
From Macrophage Cytokines: Involvement in Immunity and Infectious Diseases (2014) · cites this paper as [102]
The cited source says what the claim attributes to it.
In the citing paper
“These effects were found not to be due to mycolactone disrupting ER membrane integrity or due to induction of ER-associated degradation pathways.”
From Macrophage Cytokines: Involvement in Immunity and Infectious Diseases (2014) · cites this paper as [102]
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Powley, I. R., Kondrashov, A., Young, L. A., Dobbyn, H. C., Hill, K., Cannell, I. G., Stoneley, M., Kong, Y.-W., Cotes, J. A., Smith, G. C. M., et al. (2009) · Genes & Development · doi:10.1101/gad.516509 · Cited by 150
Self-citationRetractedIngolia, N. T., Lareau, L. F., & Weissman, J. S. (2011) · Cell · doi:10.1016/j.cell.2011.10.002 · Cited by 2,187 · cited 1×
“Puromycin (PURO) causes premature termination and ribosomal release from translating mRNAs, whereas homoharringtonine (HH) prevents translation initiation leading to ribosome run-off of translating mRNAs) [22,23].”
BackgroundX-ray structure of a protein-conducting channel
Berg, B. V. D., Clemons, W. M., Collinson, I., Modis, Y., Hartmann, E., Harrison, S. C., & Rapoport, T. A. (2004) · Nature · doi:10.1038/nature02218 · Cited by 1,250
Protein translocation across the eukaryotic endoplasmic reticulum and bacterial plasma membranes.
Rapoport, T. A. (2007) · Nature · doi:10.1038/nature06384 · Cited by 977 · cited 1×
“Since TNF and IL-6 are secreted proteins and Cox-2, is ER-resident and contains a signal peptide, their actively-translating, nascent polypeptide chains should be directly associated with the ER due to the interaction of the signal peptide with the signal recognition particle (SRP) and Sec61 complex [24].”
BackgroundInflammasome activation and IL-1β and IL-18 processing during infection
van de Veerdonk, F. L., Netea, M. G., Dinarello, C. A., & Joosten, L. A. B. (2011) · Trends in Immunology · doi:10.1016/j.it.2011.01.003 · Cited by 691 · cited 1×
“and are secreted by an unconventional mechanism following cleavage of the cytosolic pro-isoforms in a caspase- and inflammasome-dependent manner [40].”
Background[6] Preparation of microsomal membranes for cotranslational protein translocation
Walter, P., & Blobel, G. (1983) · Methods in Enzymology · doi:10.1016/s0076-6879(83)96010-x · Cited by 663 · cited 1×
“Where used, canine microsomal membrane (CPMM) preparations (Promega, or prepared in house [58]; a kind gift of Prof Barnhard Dobberstein [University of Heidelberg]) or semi-permeabilised RAW264.”
MethodMycolactone: A Polyketide Toxin from Mycobacterium ulcerans Required for Virulence
George, K. M., Chatterjee, D., Gunawardana, G., Welty, D., Hayman, J., Lee, R., & Small, P. L. C. (1999) · Science · doi:10.1126/science.283.5403.854 · Cited by 641 · cited 2×
“For instance, the delay between injection of even 100 mg of mycolactone into guinea pig and ulcer formation is 5 days [1], although some early signs of apoptosis are evident from 2 days [7].”
BackgroundP2X7 Receptor Differentially Couples to Distinct Release Pathways for IL-1β in Mouse Macrophage
Pelegrin, P., Barroso-Gutierrez, C., & Surprenant, A. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.11.7147 · Cited by 410 · cited 1×
“S3C) as they lack the required ASC (Apoptotic speck protein containing a caspase recruitment domain [41]), and so they were not studied further here.”
BackgroundWASP: a key immunological multitasker
Thrasher, A. J., & Burns, S. O. (2010) · Nature Reviews Immunology · doi:10.1038/nri2724 · Cited by 406 · cited 1×
“Mutations in human WASP are associated with a range of immune dysfunction disorders and WASP has also been implicated in Golgi to ER transport [45,46].”
BackgroundGiant plasmid-encoded polyketide synthases produce the macrolide toxin of Mycobacterium ulcerans
Stinear, T. P., Mve-Obiang, A., Small, P. L. C., Frigui, W., Pryor, M. J., Brosch, R., Jenkin, G. A., Johnson, P. D. R., Davies, J. K., Lee, R. E., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0305877101 · Cited by 389 · cited 1×
“immune responses [1,3].”
Signalling, inflammation and arthritis: NF- B and its relevance to arthritis and inflammation
Simmonds, R. E., & Foxwell, B. M. (2008) · Rheumatology · doi:10.1093/rheumatology/kem298 · Cited by 381
Self-citationPost-transcriptional control of cytokine production
Anderson, P. (2008) · Nature Immunology · doi:10.1038/ni1584 · Cited by 376 · cited 1×
“1D), due to the known translational derepression that occurs following stimulation [21].”
BackgroundCell Elasticity Determines Macrophage Function
Patel, N. R., Bole, M., Chen, C., Hardin, C. C., Kho, A. T., Mih, J., Deng, L., Butler, J., Tschumperlin, D., Fredberg, J. J., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0041024 · Cited by 275 · cited 1×
“In contrast to previous reports in human macrophages [37], wiskostatin itself had an inhibitory effect on TNFa secretion in RAW264.”
ResultJOHANNES, G., & SARNOW, P. (1998) · RNA · doi:10.1017/s1355838298981080 · Cited by 264 · cited 1×
“tion was carried out according to a previously published method [56,57].”
MethodTail-anchored membrane protein insertion into the endoplasmic reticulum
Hegde, R. S., & Keenan, R. J. (2011) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3226 · Cited by 262
George, K. M., Pascopella, L., Welty, D. M., & Small, P. L. C. (2000) · Infection and Immunity · doi:10.1128/iai.68.2.877-883.2000 · Cited by 256 · cited 2×
“For instance, the delay between injection of even 100 mg of mycolactone into guinea pig and ulcer formation is 5 days [1], although some early signs of apoptosis are evident from 2 days [7].”
BackgroundBuruli ulcer: reductive evolution enhances pathogenicity of Mycobacterium ulcerans
Demangel, C., Stinear, T. P., & Cole, S. T. (2009) · Nature Reviews Microbiology · doi:10.1038/nrmicro2077 · Cited by 197 · cited 7×
“This technique allows the association of TNF, IL-6 and Cox-2 transcripts with actively translating polysomes in various experimental conditions to be assessed.”
BackgroundResultInfluentialWang, Q., Shinkre, B. A., Lee, J.-G., Weniger, M. A., Liu, Y., Chen, W., Wiestner, A., Trenkle, W. C., & Ye, Y. (2010) · PLoS ONE · doi:10.1371/journal.pone.0015479 · Cited by 161 · cited 1×
“In addition to its ability to inhibit entry into the ER, ES1 also inhibits ERAD driven exit and triggers an unfolded protein response ([43,44] and data not shown).”
BackgroundA substrate-specific inhibitor of protein translocation into the endoplasmic reticulum
Garrison, J. L., Kunkel, E. J., Hegde, R. S., & Taunton, J. (2005) · Nature · doi:10.1038/nature03821 · Cited by 158 · cited 2×
“Inhibition of the Sec61 translocon by small molecule inhibitors, rather than causing accumulation of proteins intended for export in the cytoplasm, tends to trigger rapid degradation of the mislocalised proteins [29,30], similarly to mycolactone.”
BackgroundLuna, A., Matas, O. B., Martı́nez-Menárguez, J. A., Mato, E., Durán, J. M., Ballesta, J., Way, M., & Egea, G. (2002) · Molecular Biology of the Cell · doi:10.1091/mbc.01-12-0579 · Cited by 155 · cited 1×
“Mutations in human WASP are associated with a range of immune dysfunction disorders and WASP has also been implicated in Golgi to ER transport [45,46].”
BackgroundCoutanceau, E., Marsollier, L., Brosch, R., Perret, E., Goossens, P., Tanguy, M., Cole, S. T., Small, P. L. C., & Demangel, C. (2005) · Cellular Microbiology · doi:10.1111/j.1462-5822.2005.00546.x · Cited by 152 · cited 1×
“Infection is accompanied by alterations in local and systemic immune responses in which mycolactone plays a central role [11–14], via direct and indirect effects on T-cells, dendritic cells, monocytes and macrophages [5,15–17].”
BackgroundApratoxin A Reversibly Inhibits the Secretory Pathway by Preventing Cotranslational Translocation
Liu, Y., Law, B. K., & Luesch, H. (2009) · Molecular Pharmacology · doi:10.1124/mol.109.056085 · Cited by 151 · cited 1×
“Apratoxin A causes a wide inhibition of protein secretion but, also differs from mycolactone because its effects are completely reversible [42].”
BackgroundPartitioning and translation of mRNAs encoding soluble proteins on membrane-bound ribosomes
LERNER, R. S., SEISER, R. M., ZHENG, T., LAGER, P. J., REEDY, M. C., KEENE, J. D., & NICCHITTA, C. V. (2003) · RNA · doi:10.1261/rna.5610403 · Cited by 150 · cited 1×
“As seen by others, GAPDH mRNA was fairly evenly distributed between cytosolic and membrane fractions [25,26], but the mRNAs for TNF, Cox-2 and IL-6 were all predominantly in the membrane fraction, even in the presence of mycolactone, indicating sufficient synthesis had occurred to allow signal peptide recognition (Fig.”
BackgroundWilson, R., Allen, A. J., Oliver, J. D., Brookman, J. L., High, S., & Bulleid, N. J. (1995) · Biochemical Journal · doi:10.1042/bj3070679 · Cited by 148 · cited 1×
“7 cell extracts freshly prepared as described in [59] were added to a final concentration of 10%.”
MethodSelf-citationAdusumilli, S., Mve-Obiang, A., Sparer, T., Meyers, W., Hayman, J., & Small, P. L. C. (2005) · Cellular Microbiology · doi:10.1111/j.1462-5822.2005.00557.x · Cited by 142
Pahlevan, A. A., Wright, D. J., Andrews, C., George, K. M., Small, P. L. C., & Foxwell, B. M. J. (1999) · PubMed · Cited by 138
Selective inhibition of cotranslational translocation of vascular cell adhesion molecule 1
Besemer, J., Harant, H., Wang, S. V., Oberhauser, B., Marquardt, K., Foster, C. A., Schreiner, E. P., de Vries, J. E., Dascher-Nadel, C., & Lindley, I. J. D. (2005) · Nature · doi:10.1038/nature03670 · Cited by 131 · cited 1×
“Inhibition of the Sec61 translocon by small molecule inhibitors, rather than causing accumulation of proteins intended for export in the cytoplasm, tends to trigger rapid degradation of the mislocalised proteins [29,30], similarly to mycolactone.”
BackgroundSelective suppression of dendritic cell functions by Mycobacterium ulcerans toxin mycolactone
Coutanceau, E., Decalf, J., Martino, A., Babon, A., Winter, N., Cole, S. T., Albert, M. L., & Demangel, C. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20070234 · Cited by 131 · cited 6×
“Infection is accompanied by alterations in local and systemic immune responses in which mycolactone plays a central role [11–14], via direct and indirect effects on T-cells, dendritic cells, monocytes and macrophages [5,15–17].”
BackgroundInfluentialPahlevan, A. A., Wright, D. J. M., Andrews, C., George, K. M., Small, P. L. C., & Foxwell, B. M. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.7.3928 · Cited by 127
Mycolactone activation of Wiskott-Aldrich syndrome proteins underpins Buruli ulcer formation
Guenin‐Macé, L., Veyron‐Churlet, R., Thoulouze, M., Romet‐Lemonne, G., Hong, H., Leadlay, P. F., Danckaert, A., Ruf, M., Mostowy, S., Zurzolo, C., et al. (2013) · Journal of Clinical Investigation · doi:10.1172/jci66576 · Cited by 123 · cited 15×
“Mycolactone is a lipid-like molecule that is reportedly present in the cytoplasm of treated cells [8,32], but an inhibition of translocation suggests that it may be interacting with the ER membrane in some way.”
BackgroundInfluentialBiogenesis of tail-anchored proteins: the beginning for the end?
Rabu, C., Schmid, V., Schwappach, B., & High, S. (2009) · Journal of Cell Science · doi:10.1242/jcs.041210 · Cited by 120 · cited 1×
“Such proteins, including the b subunit of the Sec61 complex (Sec61b) and cytochrome B5 (Cyt-B5), are inserted into the ER membrane in a post-translational, Sec61independent, manner [33], and are subsequently glycosylated on artificial C-terminal reporters (Fig.”
BackgroundSelf-citationTokunaga, F., Brostrom, C., Koide, T., & Arvan, P. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m001073200 · Cited by 119 · cited 9×
“First, we examined whether it might activate ERassociated degradation (ERAD) since this pathway can recognise unfolded proteins, deglycosylate and then degrade them in a ubiquitin-dependent manner.”
InfluentialMbonye, U. R., Wada, M., Rieke, C. J., Tang, H.-Y., DeWitt, D. L., & Smith, W. L. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m608281200 · Cited by 109
Eeyarestatin I inhibits Sec61-mediated protein translocation at the endoplasmic reticulum
Cross, B. C. S., McKibbin, C., Callan, A. C., Roboti, P., Piacenti, M., Rabu, C., Wilson, C. M., Whitehead, R., Flitsch, S. L., Pool, M. R., et al. (2009) · Journal of Cell Science · doi:10.1242/jcs.054494 · Cited by 109 · cited 4×
“Membranes were recovered as described [31] by centrifugation through 750 mM sucrose, 500 mM KOAc, 5 mM Mg(OAc)2, 50 mM HEPES-KOH (pH 7.”
BackgroundMethodSelf-citationAzzam, M. E., & Algranati, I. D. (1973) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.70.12.3866 · Cited by 108 · cited 1×
“Puromycin (PURO) causes premature termination and ribosomal release from translating mRNAs, whereas homoharringtonine (HH) prevents translation initiation leading to ribosome run-off of translating mRNAs) [22,23].”
BackgroundParadoxical Responses After Start of Antimicrobial Treatment in Mycobacterium ulcerans Infection
Nienhuis, W. A., Stienstra, Y., Abass, K. M., Tuah, W., Thompson, W. A., Awuah, P. C., Awuah-Boateng, N. Y., Adjei, O., Bretzel, G., Schouten, J. P., et al. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/cir856 · Cited by 108 · cited 1×
“Treatment with antibiotics is often accompanied by increased swelling and ulceration, or even the appearance of new lesions [49].”
BackgroundInfection with Mycobacterium ulcerans Induces Persistent Inflammatory Responses in Mice
Oliveira, M. S., Fraga, A. G., Torrado, E., Castro, A. G., Pereira, J. P., Filho, A. L., Milanezi, F., Schmitt, F. C., Meyers, W. M., Portaels, F., et al. (2005) · Infection and Immunity · doi:10.1128/iai.73.10.6299-6310.2005 · Cited by 107 · cited 1×
“In ulcerated lesions, where large amounts of mycolactone are produced by foci of extracellular bacilli, inflammatory cell infiltration is limited to the periphery [9–11].”
BackgroundMycolactone inhibits monocyte cytokine production by a posttranscriptional mechanism
Simmonds, R. E., Lali, F. V., Smallie, T., Small, P. L. C., & Foxwell, B. M. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0802294 · Cited by 106 · cited 12×
“This technique allows the association of TNF, IL-6 and Cox-2 transcripts with actively translating polysomes in various experimental conditions to be assessed.”
BackgroundMethodResultSelf-citationImmune Response to Infection with Mycobacterium ulcerans
Gooding, T. M., Johnson, P. D. R., Campbell, D. E., Hayman, J. A., Hartland, E. L., Kemp, A. S., & Robins-Browne, R. M. (2001) · Infection and Immunity · doi:10.1128/iai.69.3.1704-1707.2001 · Cited by 104 · cited 1×
“This would include those involved in aspects of adaptive immunity driven by maturation markers and costimulatory molecules on dendritic cells [16] where an inability to produce these proteins would lead to a failure to interact with lymphocytes, causing the T cell anergy seen in BU [2,47,48].”
BackgroundTorrado, E., Adusumilli, S., Fraga, A. G., Small, P. L. C., Castro, A. G., & Pedrosa, J. (2007) · Infection and Immunity · doi:10.1128/iai.00290-07 · Cited by 95 · cited 1×
“In addition, mycolactone prevents the induction of many proteins essential for driving inflammation, including TNF, other cytokines/chemokines (for example, IL-6, IL-8 and IP-10), and further inflammatory mediators (such as the prostaglandin synthetase Cox-2) [5,10,15].”
BackgroundUptake and cellular actions of mycolactone, a virulence determinant for Mycobacterium ulcerans
Snyder, D. S., & Small, P. L. C. (2003) · Microbial Pathogenesis · doi:10.1016/s0882-4010(02)00210-3 · Cited by 95 · cited 1×
“Mycolactone is a lipid-like molecule that is reportedly present in the cytoplasm of treated cells [8,32], but an inhibition of translocation suggests that it may be interacting with the ER membrane in some way.”
BackgroundHong, H., Coutanceau, E., Leclerc, M., Caleechurn, L., Leadlay, P. F., & Demangel, C. (2008) · PLoS Neglected Tropical Diseases · doi:10.1371/journal.pntd.0000325 · Cited by 92 · cited 2×
“In ulcerated lesions, where large amounts of mycolactone are produced by foci of extracellular bacilli, inflammatory cell infiltration is limited to the periphery [9–11].”
BackgroundPhillips, R., Sarfo, F. S., Guenin‐Macé, L., Decalf, J., Wansbrough‐Jones, M., Albert, M. L., & Demangel, C. (2009) · The Journal of Infectious Diseases · doi:10.1086/646615 · Cited by 87 · cited 2×
“S3B and C), especially since others have previously shown that both are mycolactone targets in other systems [16,18].”
BackgroundRajan, R. S., Tsumoto, K., Tokunaga, M., Tokunaga, H., Kita, Y. A., & Arakawa, T. (2010) · Current Medicinal Chemistry · doi:10.2174/092986711793979698 · Cited by 83 · cited 9×
“First, we examined whether it might activate ERassociated degradation (ERAD) since this pathway can recognise unfolded proteins, deglycosylate and then degrade them in a ubiquitin-dependent manner.”
InfluentialMycolactone impairs T cell homing by suppressing microRNA control of L-selectin expression
Guenin‐Macé, L., Carrette, F., Asperti-Boursin, F., Bon, A. L., Caleechurn, L., Bartolo, V. D., Fontanet, A. L., Bismuth, G., & Demangel, C. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1016496108 · Cited by 83 · cited 3×
“Likewise, the loss in T cell homing has been attributed to loss of receptor expression and this powerful mechanism of suppression would substantially add to the effect of let-7b [6].”
BackgroundBoulkroun, S., Guenin-Macé, L., Thoulouze, M.-I., Monot, M., Merckx, A., Langsley, G., Bismuth, G., Di Bartolo, V., & Demangel, C. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0902854 · Cited by 83 · cited 4×
“4D) and CCR7 [17] escape this translocation block.”
BackgroundResultInfluentialSchütte, D., Um-Boock, A., Mensah‐Quainoo, E., Itin, P. H., Schmid, P., & Pluschke, G. (2007) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0000002 · Cited by 76 · cited 2×
“There is good evidence that mycolactone diffuses through the lesion in advance of the proliferating bacilli and the necrotic centre (see for example [20]).”
BackgroundTotal Synthesis of the Mycolactones
Song, F., Fidanze, S. D., Benowitz, A. B., & Kishi, Y. (2002) · Organic Letters · doi:10.1021/ol0172828 · Cited by 75
κ-Casein-deficient mice fail to lactate
Shekar, P. C., Goel, S., Rani, S. D. S., Sarathi, D. P., Alex, J. L., Singh, S., & Kumar, S. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0601611103 · Cited by 70
Acquired T‐helper 1 Lymphocyte Anergy Following Infection with Mycobacterium ulcerans
Gooding, T. M., Kemp, A. S., Robins‐Browne, R. M., Smith, M., & Johnson, P. D. R. (2003) · Clinical Infectious Diseases · doi:10.1086/368315 · Cited by 61 · cited 1×
“This would include those involved in aspects of adaptive immunity driven by maturation markers and costimulatory molecules on dendritic cells [16] where an inability to produce these proteins would lead to a failure to interact with lymphocytes, causing the T cell anergy seen in BU [2,47,48].”
BackgroundFraga, A. G., Cruz, A., Martins, T. G., Torrado, E., Saraiva, M., Pereira, D. R., Meyers, W. M., Portaels, F., Silva, M. T., Castro, A. G., et al. (2010) · Infection and Immunity · doi:10.1128/iai.00820-10 · Cited by 60 · cited 1×
“Infection is accompanied by alterations in local and systemic immune responses in which mycolactone plays a central role [11–14], via direct and indirect effects on T-cells, dendritic cells, monocytes and macrophages [5,15–17].”
BackgroundHall, B., & Simmonds, R. (2014) · Biochemical Society Transactions · doi:10.1042/bst20130133 · Cited by 52 · cited 3×
“lines, but the dose and exposure required is highly variable ([4]”
BackgroundSelf-citationStephens, S. B., Dodd, R. D., Lerner, R. S., Pyhtila, B. M., & Nicchitta, C. V. (2008) · Methods In Molecular Biology™ · doi:10.1007/978-1-59745-033-1_14 · Cited by 47 · cited 2×
“method [26] with minor alterations (full protocol in Information S1).”
BackgroundMethodSarfo, F. S., Converse, P. J., Almeida, D. V., Zhang, J., Robinson, C., Wansbrough-Jones, M. H., & Grosset, J. H. E. (2013) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0002101 · Cited by 46 · cited 2×
“ulcerans to synthesise mycolactone and that this is the more important factor in recovery [51,52].”
BackgroundMcKibbin, C., Mares, A., Piacenti, M., Williams, H., Roboti, P., Puumalainen, M., Callan, A. C., Lesiak-Mieczkowska, K., Linder, S., Harant, H., et al. (2012) · Biochemical Journal · doi:10.1042/bj20111220 · Cited by 42 · cited 1×
“In addition to its ability to inhibit entry into the ER, ES1 also inhibits ERAD driven exit and triggers an unfolded protein response ([43,44] and data not shown).”
BackgroundSelf-citationEfficient sorting of TNF‐alpha to rodent mast cell granules is dependent on N‐linked glycosylation
Olszewski, M. B., Trzaska, D., Knol, E. F., Cecuda-Adamczewska, V., & Dastych, J. (2006) · European Journal of Immunology · doi:10.1002/eji.200535323 · Cited by 31 · cited 1×
“3A) it does slows transit through the ER and Golgi allowing detection of pro-TNF in lysates [28] (Fig.”
BackgroundMartins, T. G., Gama, J. B., Fraga, A. G., Saraiva, M., Silva, M. T., Castro, A. G., & Pedrosa, J. (2012) · PLoS ONE · doi:10.1371/journal.pone.0032740 · Cited by 29 · cited 1×
“Several studies in both human patients and animal models have shown that a progressive and structured immune response follows initiation of therapy with the standard rifampicin/streptomycin combination [20,50,51].”
BackgroundPotential of rifamides to inhibit TNF-induced NF-kappaB activation
Pahlevan, A. A., Wright, D. J. M., Bradley, L., Smith, C., & Foxwell, B. M. J. (2002) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/49.3.531 · Cited by 27 · cited 2×
“enhanced by exposure to the drug, others are blocked [53,54].”
BackgroundMartins, T. G., Trigo, G., Fraga, A. G., Gama, J. B., Longatto‐Filho, A., Saraiva, M., Silva, M. T., Castro, A. G., & Pedrosa, J. (2012) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0001925 · Cited by 26 · cited 1×
“Mycolactone inhibits key macrophage responses such as nitric oxide production and phagocytosis as well as phagosome maturation and acidification [2,4,19].”
BackgroundEffect of Rifampin on Production of Inflammatory Mediators in HepG2 Liver Epithelial Cells
Yuhas, Y., Berent, E., & Ashkenazi, S. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.05149-11 · Cited by 25 · cited 1×
“enhanced by exposure to the drug, others are blocked [53,54].”
BackgroundAlmeida, D. V., Converse, P. J., Li, S., Tyagi, S. K., Nuermberger, E. L., & Grosset, J. H. E. (2013) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0002085 · Cited by 16 · cited 1×
“ulcerans to synthesise mycolactone and that this is the more important factor in recovery [51,52].”
Background
Cited by
Macrophage Cytokines: Involvement in Immunity and Infectious Diseases
Arango Duque, G., & Descoteaux, A. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00491 · Cited by 2,708
“Importantly, mycolactone blocked the release of several cytokines, chemokines, and other inflammatory mediators from LPS-activated macrophages (102).”
BackgroundMethodInfluentialGuidelines for the use and interpretation of assays for monitoring autophagy (4th edition) 1
Klionsky, D. J., Abdel-Aziz, A. K., Abdelfatah, S., Abdellatif, M., Abdoli, A., Abel, S., Abeliovich, H., Abildgaard, M. H., Abudu, Y. P., Acevedo-Arozena, A., et al. (2021) · Autophagy · doi:10.1080/15548627.2020.1797280 · Cited by 2,897
Current Concepts of Antigen Cross-Presentation
Embgenbroich, M., & Burgdorf, S. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01643 · Cited by 397
“It is generally assumed that members of the ER-associated degradation (ERAD) machinery contribute in enabling antigen dislocation for cross-presentation.”
BackgroundInfluentialCutaneous Mycobacterial Infections
Franco-Paredes, C., Marcos, L. A., Henao-Martínez, A. F., Rodríguez-Morales, A. J., Villamil-Gómez, W. E., Gotuzzo, E., & Bonifaz, A. (2018) · Clinical Microbiology Reviews · doi:10.1128/cmr.00069-18 · Cited by 289
“ulcerans causes tissue destruction (111, 113), local immunosuppression through the inhibition of protein translocation into the endoplasmic reticulum of cytokines of the innate immune system, membrane receptors, adhesion molecules, and T-cell-dependent cytokines (114).”
BackgroundZika virus induces massive cytoplasmic vacuolization and paraptosis‐like death in infected cells
Monel, B., Compton, A. A., Bruel, T., Amraoui, S., Burlaud‐Gaillard, J., Roy, N., Guivel‐Benhassine, F., Porrot, F., Génin, P., Meertens, L., et al. (2017) · The EMBO Journal · doi:10.15252/embj.201695597 · Cited by 164
“…blocks the biogenesis of secretory and integral membrane proteins by inhibiting the Sec61 translocon, the channel guiding nascent polypeptides into the ER lumen (Hall et al , 2014; Guenin-Mace et al , 2015; Kalies & Romisch, 2015; Baron et al , 2016; McKenna et al , 2016; Ravindran et al , 2016).”
Metadata
- Authors
- Hall, B. S., Hill, K., McKenna, M., Ogbechi, J., High, S., Willis, A. E., & Simmonds, R. E.
- Affiliations
- University of Surrey (GB)
- Babraham Institute (GB)
- University of Manchester (GB)
- Corresponding author
- Simmonds, Rachel E.
- Venue
- PLoS Pathogens
- Publisher
- Public Library of Science (PLoS)
- Published
- 2014-04-03
- Volume
- 10
- Issue
- 4
- Pages
- e1004061
- ISSN
- 1553-7366 (ISSN-L)
- 1553-7374
- PMC
- PMC3974873
- OpenAlex
- W2061277860
- Semantic Scholar
- 5212d6d5ae6ba36ce1c7bcab6a815efbff42e4ad
- Cited by
- 162
- References
- 61
- Citations by year
- 2026: 6 · 2025: 11 · 2024: 6 · 2023: 24 · 2022: 16 · 2021: 14 · 2020: 12 · 2019: 17 · 2018: 15 · 2017: 13 · 2016: 7 · 2015: 12 · 2014: 9
- FWCI
- 10.27
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS Pathogens (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Research Explorer (The University of Manchester) (publishedVersion, other-oa)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Surrey Research Insight Open Access (The University of Surrey) (submittedVersion)
- Figshare (submittedVersion, cc-by)
- Apollo (University of Cambridge) (submittedVersion, cc-by)
- Apollo (cc-by)
- Funders
- Harvard University
- Wellcome Trust (WT092744)
- Biotechnology and Biological Sciences Research Council (BB/F02326X/2, 1338405, 1626839)
- Topics
- Health Sciences › Medicine › Epidemiology › Mycobacterium research and diagnosis
- Health Sciences › Medicine › Infectious Diseases › Tuberculosis Research and Epidemiology
- Health Sciences › Medicine › Infectious Diseases › Leprosy Research and Treatment
- Keywords
- Mycobacterium ulcerans, mycolactone, Buruli ulcer, virulence factors, protein translocation, endoplasmic reticulum, protein degradation, 26S proteasome, TNF-α, interleukin-6, cyclooxygenase-2, macrophages, glycosylated proteins, secreted proteins, immunosuppression, tissue necrosis, post-transcriptional regulation
- MeSH terms
- Animals, Cell Line, Endoplasmic Reticulum, Lipopolysaccharides, Protein Biosynthesis, Tumor Necrosis Factor-alpha, Cell Adhesion Molecules, Interleukin-6, Inflammation Mediators, Macrolides, Mycobacterium ulcerans, Protein Transport, Mice, Cyclooxygenase 2, Buruli Ulcer
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.